Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 67

1.

Novel EUS-guided brachytherapy treatment of pancreatic cancer with phosphorus-32 microparticles: first United States experience.

Bhutani MS, Cazacu IM, Luzuriaga Chavez AA, Singh BS, Wong FCL, Erwin WD, Tamm EP, Mathew GG, Le DB, Koay EJ, Taniguchi CM, Minsky BD, Pant S, Tzeng CD, Koong AC, Varadhachary GR, Katz MHG, Wolff RA, Fogelman DR, Herman JM.

VideoGIE. 2019 Apr 29;4(5):223-225. doi: 10.1016/j.vgie.2019.02.009. eCollection 2019 May. No abstract available.

2.

A personalized, Monte Carlo-based method for internal dosimetric evaluation of radiopharmaceuticals in children.

Papadimitroulas P, Erwin WD, Iliadou V, Kostou T, Loudos G, Kagadis GC.

Med Phys. 2018 Jun 19. doi: 10.1002/mp.13055. [Epub ahead of print]

PMID:
29920693
3.

Updated Results of Rituximab Pre- and Post-BEAM with or without 90Yttrium Ibritumomab Tiuxetan during Autologous Transplant for Diffuse Large B-cell Lymphoma.

Chahoud J, Sui D, Erwin WD, Gulbis AM, Korbling M, Zhang M, Ahmed S, Alatrash G, Anderlini P, Ciurea SO, Oran B, Fayad LE, Bassett RL Jr, Jabbour EJ, Medeiros LJ, Macapinlac HA, Young KH, Khouri IF.

Clin Cancer Res. 2018 May 15;24(10):2304-2311. doi: 10.1158/1078-0432.CCR-17-3561. Epub 2018 Feb 23.

4.

AAPM medical physics practice guideline 6.a.: Performance characteristics of radiation dose index monitoring systems.

Gress DA, Dickinson RL, Erwin WD, Jordan DW, Kobistek RJ, Stevens DM, Supanich MP, Wang J, Fairobent LA.

J Appl Clin Med Phys. 2017 Jul;18(4):12-22. doi: 10.1002/acm2.12089. Epub 2017 May 12.

5.
6.

Evaluation of a deterministic grid-based Boltzmann solver (GBBS) for voxel-level absorbed dose calculations in nuclear medicine.

Mikell J, Cheenu Kappadath S, Wareing T, Erwin WD, Titt U, Mourtada F.

Phys Med Biol. 2016 Jun 21;61(12):4564-82. doi: 10.1088/0031-9155/61/12/4564. Epub 2016 May 25.

PMID:
27224727
7.

Skeletal Tumor Burden on Baseline 18F-Fluoride PET/CT Predicts Bone Marrow Failure After 223Ra Therapy.

Etchebehere EC, Araujo JC, Milton DR, Erwin WD, Wendt RE 3rd, Swanston NM, Fox P, Macapinlac HA, Rohren EM.

Clin Nucl Med. 2016 Apr;41(4):268-73. doi: 10.1097/RLU.0000000000001118.

PMID:
26828141
8.

Correction Techniques in Emission Tomography.

Erwin WD.

Med Phys. 2013 Jul;40(7). doi: 10.1118/1.4811098.

PMID:
28524932
9.

Nonmyeloablative allogeneic transplantation with or without 90yttrium ibritumomab tiuxetan is potentially curative for relapsed follicular lymphoma: 12-year results.

Khouri IF, Saliba RM, Erwin WD, Samuels BI, Korbling M, Medeiros LJ, Valverde R, Alousi AM, Anderlini P, Bashir Q, Ciurea S, Gulbis AM, de Lima M, Hosing C, Kebriaei P, Popat UR, Fowler N, Neelapu SS, Samaniego F, Champlin RE, Macapinlac HA.

Blood. 2012 Jun 28;119(26):6373-8. doi: 10.1182/blood-2012-03-417808. Epub 2012 May 14.

10.

A preclinical investigation of the saturation and dosimetry of 153Sm-DOTMP as a bone-seeking radiopharmaceutical.

Simón J, Frank RK, Crump DK, Erwin WD, Ueno NT, Wendt RE 3rd.

Nucl Med Biol. 2012 Aug;39(6):770-6. doi: 10.1016/j.nucmedbio.2011.12.015. Epub 2012 Mar 28.

11.

Hybrid Modality Fusion of Planar Scintigrams and CT Topograms to Localize Sentinel Lymph Nodes in Breast Lymphoscintigraphy: Technical Description and Phantom Studies.

Dickinson RL, Erwin WD, Stevens DM, Bidaut LM, Mar MV, Macapinlac HA, Wendt RE 3rd.

Int J Mol Imaging. 2011;2011:298102. doi: 10.1155/2011/298102. Epub 2010 Dec 14.

12.

Seasonal regulation of social communication by photoperiod and testosterone: effects of arginine-vasopressin, serotonin and galanin in the medial preoptic area-anterior hypothalamus.

Gutzler SJ, Karom M, Erwin WD, Albers HE.

Behav Brain Res. 2011 Jan 1;216(1):214-9. doi: 10.1016/j.bbr.2010.07.042. Epub 2010 Aug 7.

PMID:
20696187
13.

Arginine-vasopressin and the regulation of aggression in female Syrian hamsters (Mesocricetus auratus).

Gutzler SJ, Karom M, Erwin WD, Albers HE.

Eur J Neurosci. 2010 May;31(9):1655-63. doi: 10.1111/j.1460-9568.2010.07190.x.

PMID:
20525078
14.

Acquisition parameters for oncologic imaging with a new SPECT/multislice CT scanner.

Núñez R, Erwin WD, Wendt RE 3rd, Stachowiak A, Mar M, Stevens D, Madewell JE, Yeung HW, Macapinlac HA.

Mol Imaging Biol. 2010 Apr;12(2):110-38. doi: 10.1007/s11307-009-0266-4. Epub 2010 Jan 5. Review.

PMID:
20049543
15.

Effect of voxel size and computation method on Tc-99m MAA SPECT/CT-based dose estimation for Y-90 microsphere therapy.

Pasciak AS, Erwin WD.

IEEE Trans Med Imaging. 2009 Nov;28(11):1754-8. doi: 10.1109/TMI.2009.2022753.

PMID:
19884064
16.

Photoperiodic regulation of adrenal hormone secretion and aggression in female Syrian hamsters.

Gutzler SJ, Karom M, Erwin WD, Albers HE.

Horm Behav. 2009 Oct;56(4):481-9. doi: 10.1016/j.yhbeh.2009.08.007. Epub 2009 Aug 27.

17.

Gonadal hormones modulate the display of conditioned defeat in male Syrian hamsters.

Solomon MB, Karom MC, Norvelle A, Markham CA, Erwin WD, Huhman KL.

Horm Behav. 2009 Oct;56(4):423-8. doi: 10.1016/j.yhbeh.2009.07.011. Epub 2009 Aug 3.

18.

A novel method to evaluate gamma camera rotational uniformity and sensitivity variation.

Kappadath SC, Erwin WD, Wendt RE 3rd.

Med Phys. 2009 Jun;36(6):1947-55.

19.

Estimation of yttrium-90 Zevalin tumor-absorbed dose in ocular adnexal lymphoma using quantitative indium-111 Zevalin radionuclide imaging.

Erwin WD, Esmaeli B.

Nucl Med Commun. 2009 Sep;30(9):681-6. doi: 10.1097/MNM.0b013e32832a6e4d.

PMID:
19528874
20.

Radiation dosimetry and biodistribution of (99m)Tc-ethylene dicysteine-deoxyglucose in patients with non-small-cell lung cancer.

Schechter NR, Erwin WD, Yang DJ, Kim EE, Munden RF, Forster K, Taing LC, Cox JD, Macapinlac HA, Podoloff DA.

Eur J Nucl Med Mol Imaging. 2009 Oct;36(10):1583-91. doi: 10.1007/s00259-009-1135-8. Epub 2009 Apr 25.

21.

Optimal (57)Co flood source activity and acquisition time for lymphoscintigraphy localization images.

Mar MV, Dickinson RL, Erwin WD, Wendt RE 3rd.

J Nucl Med Technol. 2008 Jun;36(2):82-7. doi: 10.2967/jnmt.107.047043. Epub 2008 May 15.

22.

Imaging and dosimetry of 99mTc EC annexin V: preliminary clinical study targeting apoptosis in breast tumors.

Kurihara H, Yang DJ, Cristofanilli M, Erwin WD, Yu DF, Kohanim S, Mendez R, Kim EE.

Appl Radiat Isot. 2008 Sep;66(9):1175-82. doi: 10.1016/j.apradiso.2008.01.012. Epub 2008 Jan 26.

23.
24.

Preserving functional lung using perfusion imaging and intensity-modulated radiation therapy for advanced-stage non-small cell lung cancer.

Shioyama Y, Jang SY, Liu HH, Guerrero T, Wang X, Gayed IW, Erwin WD, Liao Z, Chang JY, Jeter M, Yaremko BP, Borghero YO, Cox JD, Komaki R, Mohan R.

Int J Radiat Oncol Biol Phys. 2007 Aug 1;68(5):1349-58. Epub 2007 Apr 18.

PMID:
17446001
26.

166Ho-DOTMP radiation-absorbed dose estimation for skeletal targeted radiotherapy.

Breitz HB, Wendt RE 3rd, Stabin MS, Shen S, Erwin WD, Rajendran JG, Eary JF, Durack L, Delpassand E, Martin W, Meredith RF.

J Nucl Med. 2006 Mar;47(3):534-42.

27.

The value of 99mTc-sestamibi SPECT/CT over conventional SPECT in the evaluation of parathyroid adenomas or hyperplasia.

Gayed IW, Kim EE, Broussard WF, Evans D, Lee J, Broemeling LD, Ochoa BB, Moxley DM, Erwin WD, Podoloff DA.

J Nucl Med. 2005 Feb;46(2):248-52.

28.

Radiation dosimetry of 99mTc-labeled C225 in patients with squamous cell carcinoma of the head and neck.

Schechter NR, Wendt RE 3rd, Yang DJ, Azhdarinia A, Erwin WD, Stachowiak AM, Broemeling LD, Kim EE, Cox JD, Podoloff DA, Ang KK.

J Nucl Med. 2004 Oct;45(10):1683-7.

29.

Radiation dosimetry results from a Phase II trial of ibritumomab tiuxetan (Zevalin) radioimmunotherapy for patients with non-Hodgkin's lymphoma and mild thrombocytopenia.

Wiseman GA, Leigh BR, Erwin WD, Sparks RB, Podoloff DA, Schilder RJ, Bartlett NL, Spies SM, Grillo-López AJ, Witzig TE, White CA.

Cancer Biother Radiopharm. 2003 Apr;18(2):165-78.

PMID:
12804042
30.

Radiation dosimetry results and safety correlations from 90Y-ibritumomab tiuxetan radioimmunotherapy for relapsed or refractory non-Hodgkin's lymphoma: combined data from 4 clinical trials.

Wiseman GA, Kornmehl E, Leigh B, Erwin WD, Podoloff DA, Spies S, Sparks RB, Stabin MG, Witzig T, White CA.

J Nucl Med. 2003 Mar;44(3):465-74.

31.
32.

Quantitative gated blood pool SPECT: analysis of 3-dimensional models for the assessment of regional myocardial wall motion.

Groch MW, Schippers DJ, Marshall RC, Groch PJ, Erwin WD.

J Nucl Cardiol. 2002 May-Jun;9(3):271-84.

PMID:
12032475
33.

Radiation dosimetry results for Zevalin radioimmunotherapy of rituximab-refractory non-Hodgkin lymphoma.

Wiseman GA, Leigh B, Erwin WD, Lamonica D, Kornmehl E, Spies SM, Silverman DH, Witzig TE, Sparks RB, White CA.

Cancer. 2002 Feb 15;94(4 Suppl):1349-57.

34.

Planar imaging versus gated blood-pool SPECT for the assessment of ventricular performance: a multicenter study.

Groch MW, DePuey EG, Belzberg AC, Erwin WD, Kamran M, Barnett CA, Hendel RC, Spies SM, Ali A, Marshall RC.

J Nucl Med. 2001 Dec;42(12):1773-9.

35.

Biodistribution and dosimetry results from a phase III prospectively randomized controlled trial of Zevalin radioimmunotherapy for low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma.

Wiseman GA, White CA, Sparks RB, Erwin WD, Podoloff DA, Lamonica D, Bartlett NL, Parker JA, Dunn WL, Spies SM, Belanger R, Witzig TE, Leigh BR.

Crit Rev Oncol Hematol. 2001 Jul-Aug;39(1-2):181-94.

PMID:
11418315
36.
38.

SPECT in the year 2000: basic principles.

Groch MW, Erwin WD.

J Nucl Med Technol. 2000 Dec;28(4):233-44.

39.

Quantitative gated myocardial SPECT: effect of collimation on left-ventricular ejection fraction.

Groch MW, Takamiya Y, Groch PJ, Erwin WD.

J Nucl Med Technol. 2000 Mar;28(1):36-40.

40.

The effect of remifentanil on biliary tract drainage into the duodenum.

Fragen RJ, Vilich F, Spies SM, Erwin WD.

Anesth Analg. 1999 Dec;89(6):1561-4.

PMID:
10589649
41.

Quantitative gated blood pool SPECT for the assessment of coronary artery disease at rest.

Groch MW, Marshall RC, Erwin WD, Schippers DJ, Barnett CA, Leidholdt EM Jr.

J Nucl Cardiol. 1998 Nov-Dec;5(6):567-73.

PMID:
9869478
42.

Lumbar spine duplication presenting as adolescent scoliosis. A case report.

Goldberg BA, Erwin WD, Heggeness MH.

Spine (Phila Pa 1976). 1998 Feb 15;23(4):504-7.

PMID:
9516710
43.

Prediction of radiation doses from therapy using tracer studies with iodine-131-labeled antibodies.

DeNardo DA, DeNardo GL, Yuan A, Shen S, DeNardo SJ, Macey DJ, Lamborn KR, Mahe M, Groch MW, Erwin WD.

J Nucl Med. 1996 Dec;37(12):1970-5.

44.

Validation of a knowledge-based boundary detection algorithm: a multicenter study.

Groch MW, Erwin WD, Murphy PH, Ali A, Moore W, Ford P, Qian J, Barnett CA, Lette J.

Eur J Nucl Med. 1996 Jun;23(6):662-8.

PMID:
8662100
45.

A radioimmunoimaging and MIRD dosimetry treatment planning program for radioimmunotherapy.

Erwin WD, Groch MW, Macey DJ, DeNardo GL, DeNardo SJ, Shen S.

Nucl Med Biol. 1996 May;23(4):525-32.

PMID:
8832711
46.
47.

Results of operative treatment of idiopathic scoliosis in adults.

Dickson JH, Mirkovic S, Noble PC, Nalty T, Erwin WD.

J Bone Joint Surg Am. 1995 Apr;77(4):513-23.

PMID:
7713967
48.

Body and blood clearance and marrow radiation dose of 131I-Lym-1 in patients with B-cell malignancies.

DeNardo GL, Mahe MA, DeNardo SJ, Macey DJ, Mirick GR, Erwin WD, Groch MW.

Nucl Med Commun. 1993 Jul;14(7):587-95.

PMID:
8355919
49.

A new heart-sounds gating device for medical imaging.

Groch MW, Domnanovich JR, Erwin WD.

IEEE Trans Biomed Eng. 1992 Mar;39(3):307-10.

PMID:
1555861
50.

Supplemental Content

Loading ...
Support Center